Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Letter: No Biochemical Relapse Is Associated With the Highest Off‐Therapy HBsAg Loss Rate
Letter: No Biochemical Relapse Is Associated With the Highest Off‐Therapy HBsAg Loss Rate
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Wen‐Juei Jeng
,
Yun‐Fan Liaw
Format:
Artículo Open Access
Published:
Wiley
2025
Subjects:
Alimentary Pharmacology & Therapeutics
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Description
DOI:
10.1111/apt.70061
Similar Items
Letter: No Biochemical Relapse Is Associated With the Highest Off‐Therapy HBsAg Loss Rate—Authors' Reply
by: Ying‐Nan Tsai, et al.
Published: (2025)
Letter: Dynamic HBcrAg and HBsAg After Nucleos(t)ide Analogue Cessation: Considerations in Interpreting Predictive Performance
by: Hsiang‐Ting Keng, et al.
Published: (2026)
Higher end‐of‐treatment HBsAg levels is associated with later onset but not severe relapse in HBeAg‐negative chronic hepatitis B patients stopping antivirals
by: Yen‐Chun Liu, et al.
Published: (2024)
Editorial: High qHBsAg—Is it a good or bad signal? Authors' reply
by: Hsin‐Che Lin, et al.
Published: (2024)
Dynamics of Circulatory HBcrAg and HBsAg After Nucleos(t)ide Analogue Cessation Using iTACT Assays to Predict Clinical Flares and HBsAg Loss
by: Ying‐Nan Tsai, et al.
Published: (2026)